Anyone who fails to grasp this corrupt reality is sadly mistaken.
Protecting BP profit days are gone. Enter the days of immunotherapy.
Now you know why some decided it was a chance that had to be taken: to sabotage Peregrine trials and slow them the hell down
Any other small biotech would have folded and given up to the BP powers
Peregrine Pharmaceuticals still standing, which is why a boat load of posters still here
Hopefully all are loaded up on shares on PPHM because in Time the story unfolds perfectly for PS Targeting
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!